Management of clinical infections of Escherichia coli by new β-lactam/β-lactamase inhibitor combinations

BACKGROUND AND OBJECTIVES: Escherichia coli (E. coli) is an important member of Enterobacteriaceae family involved in severe infections. The increased rate of resistance towards different classes of antibiotics limits their treatment options. The aim of this study was to assess the in vitro activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadry, Ashraf Ahmed, El-Antrawy, May Ayman, El-Ganiny, Amira Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867644/
https://www.ncbi.nlm.nih.gov/pubmed/36721515
http://dx.doi.org/10.18502/ijm.v14i4.10232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867644/
https://www.ncbi.nlm.nih.gov/pubmed/36721515
http://dx.doi.org/10.18502/ijm.v14i4.10232

Ejemplares similares